Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind Clinical Trial to Evaluate the Safety and Efficacy of Two Doses of Prolonged Release Pirfenidone, Compared Against Placebo Plus Conventional Therapy in Patients With Compensated Liver Cirrhosis.

NCT06267794 is registered in ClinicalTrials.gov with Jorge L Poo as lead sponsor.

NCT NCT06267794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06267794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind Clinical Trial to Evaluate the Safety and Efficacy of Two Doses of Prolonged Release Pirfenidone, Compared Against Placebo Plus Conventional Therapy in Patients With Compensated Liver Cirrhosis.
Lead sponsor
Jorge L Poo
Phase
Phase 2
Overall status
Completed
Start date
June 26, 2015
Completion date
March 24, 2023
Enrollment
180 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic liver disease, cirrhosis, liver, liver fibrosis